Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities
Article in DARU Journal of Pharmaceutical Sciences (April 2024)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Article in DARU Journal of Pharmaceutical Sciences (April 2024)
Article in Journal of Cancer (April 2024)
Article in European Journal of Medicinal Chemistry (March 2024)